vs

Side-by-side financial comparison of COMPUGEN LTD (CGEN) and MOVING iMAGE TECHNOLOGIES INC. (MITQ). Click either name above to swap in a different company.

MOVING iMAGE TECHNOLOGIES INC. is the larger business by last-quarter revenue ($3.8M vs $3.5M, roughly 1.1× COMPUGEN LTD). MOVING iMAGE TECHNOLOGIES INC. runs the higher net margin — -10.2% vs -410.1%, a 399.9% gap on every dollar of revenue. On growth, MOVING iMAGE TECHNOLOGIES INC. posted the faster year-over-year revenue change (10.2% vs -61.8%).

Compugen Ltd. is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Compugen was established as computational drug discovery service provider in 1993. Compugen originally acted as service provider for pharma companies, supplying its software and computational services to predict different types of biological phenomena. It had arrangements with big compan...

Silicon Image Inc. was an American fabless semiconductor company based in Hillsboro, Oregon, and active from 1995 to 2015. The company designed circuits for mobile phones, consumer electronics and personal computers (PCs). It also manufactured wireless and wired connectivity products used for high-definition content. The company's semiconductor and IP products were deployed by manufacturers in devices such as smartphones, tablets, digital televisions (DTVs), and other consumer electronics, as...

CGEN vs MITQ — Head-to-Head

Bigger by revenue
MITQ
MITQ
1.1× larger
MITQ
$3.8M
$3.5M
CGEN
Growing faster (revenue YoY)
MITQ
MITQ
+72.0% gap
MITQ
10.2%
-61.8%
CGEN
Higher net margin
MITQ
MITQ
399.9% more per $
MITQ
-10.2%
-410.1%
CGEN

Income Statement — Q2 FY2025 vs Q2 FY2026

Metric
CGEN
CGEN
MITQ
MITQ
Revenue
$3.5M
$3.8M
Net Profit
$-14.5M
$-388.0K
Gross Margin
30.7%
Operating Margin
-475.1%
-10.8%
Net Margin
-410.1%
-10.2%
Revenue YoY
-61.8%
10.2%
Net Profit YoY
-54.7%
26.4%
EPS (diluted)
$-0.16
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CGEN
CGEN
MITQ
MITQ
Q4 25
$3.8M
Q3 25
$5.6M
Q2 25
$3.5M
Q1 25
$3.6M
Q4 24
$3.4M
Q3 24
$5.3M
Q2 24
$9.3M
$6.3M
Q1 24
$2.6M
$3.9M
Net Profit
CGEN
CGEN
MITQ
MITQ
Q4 25
$-388.0K
Q3 25
$509.0K
Q2 25
$-14.5M
Q1 25
$-240.0K
Q4 24
$-527.0K
Q3 24
$-25.0K
Q2 24
$-9.4M
$-416.0K
Q1 24
$7.3M
$-601.0K
Gross Margin
CGEN
CGEN
MITQ
MITQ
Q4 25
30.7%
Q3 25
30.0%
Q2 25
Q1 25
29.8%
Q4 24
27.2%
Q3 24
26.1%
Q2 24
60.5%
22.5%
Q1 24
17.9%
17.4%
Operating Margin
CGEN
CGEN
MITQ
MITQ
Q4 25
-10.8%
Q3 25
6.3%
Q2 25
-475.1%
Q1 25
-7.6%
Q4 24
-16.3%
Q3 24
-1.3%
Q2 24
-128.5%
-7.3%
Q1 24
-16.7%
Net Margin
CGEN
CGEN
MITQ
MITQ
Q4 25
-10.2%
Q3 25
9.1%
Q2 25
-410.1%
Q1 25
-6.7%
Q4 24
-15.3%
Q3 24
-0.5%
Q2 24
-101.4%
-6.6%
Q1 24
284.0%
-15.4%
EPS (diluted)
CGEN
CGEN
MITQ
MITQ
Q4 25
$-0.04
Q3 25
$0.05
Q2 25
$-0.16
Q1 25
$-0.02
Q4 24
$-0.05
Q3 24
$0.00
Q2 24
$-0.10
$-0.04
Q1 24
$89505618.00
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CGEN
CGEN
MITQ
MITQ
Cash + ST InvestmentsLiquidity on hand
$35.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$50.3M
$5.0M
Total Assets
$106.5M
$9.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CGEN
CGEN
MITQ
MITQ
Q4 25
Q3 25
Q2 25
$35.3M
Q1 25
Q4 24
Q3 24
Q2 24
$44.6M
Q1 24
$39.3M
Stockholders' Equity
CGEN
CGEN
MITQ
MITQ
Q4 25
$5.0M
Q3 25
$5.4M
Q2 25
$50.3M
Q1 25
$5.0M
Q4 24
$5.2M
Q3 24
$5.7M
Q2 24
$58.3M
$5.7M
Q1 24
$65.6M
$6.3M
Total Assets
CGEN
CGEN
MITQ
MITQ
Q4 25
$9.5M
Q3 25
$11.3M
Q2 25
$106.5M
Q1 25
$11.2M
Q4 24
$10.0M
Q3 24
$10.7M
Q2 24
$110.2M
$10.5M
Q1 24
$121.3M
$12.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CGEN
CGEN
MITQ
MITQ
Operating Cash FlowLast quarter
$-18.6M
$-1.6M
Free Cash FlowOCF − Capex
$-18.8M
FCF MarginFCF / Revenue
-530.8%
Capex IntensityCapex / Revenue
6.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CGEN
CGEN
MITQ
MITQ
Q4 25
$-1.6M
Q3 25
$-167.0K
Q2 25
$-18.6M
Q1 25
$53.0K
Q4 24
$70.0K
Q3 24
$-32.0K
Q2 24
$39.7M
$-472.0K
Q1 24
$1.0M
Free Cash Flow
CGEN
CGEN
MITQ
MITQ
Q4 25
Q3 25
Q2 25
$-18.8M
Q1 25
Q4 24
Q3 24
Q2 24
$39.7M
Q1 24
FCF Margin
CGEN
CGEN
MITQ
MITQ
Q4 25
Q3 25
Q2 25
-530.8%
Q1 25
Q4 24
Q3 24
Q2 24
428.3%
Q1 24
Capex Intensity
CGEN
CGEN
MITQ
MITQ
Q4 25
Q3 25
Q2 25
6.5%
Q1 25
Q4 24
Q3 24
Q2 24
0.4%
0.0%
Q1 24
0.0%
Cash Conversion
CGEN
CGEN
MITQ
MITQ
Q4 25
Q3 25
-0.33×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons